These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28596972)

  • 1. Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease.
    Mårdh CK; Root J; Uddin M; Stenvall K; Malmgren A; Karabelas K; Thomas M
    J Immunol Res; 2017; 2017():5273201. PubMed ID: 28596972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
    Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
    Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice.
    Mattos MS; Ferrero MR; Kraemer L; Lopes GAO; Reis DC; Cassali GD; Oliveira FMS; Brandolini L; Allegretti M; Garcia CC; Martins MA; Teixeira MM; Russo RC
    Front Immunol; 2020; 11():566953. PubMed ID: 33123138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils.
    Gupta V; Khan A; Higham A; Lemon J; Sriskantharajah S; Amour A; Hessel EM; Southworth T; Singh D
    Int Immunopharmacol; 2016 Jun; 35():155-162. PubMed ID: 27049289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma.
    Uddin M; Watz H; Malmgren A; Pedersen F
    Front Immunol; 2019; 10():47. PubMed ID: 30804927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
    Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
    J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy.
    Pease JE; Sabroe I
    Am J Respir Med; 2002; 1(1):19-25. PubMed ID: 14720072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects.
    Todd CM; Salter BM; Murphy DM; Watson RM; Howie KJ; Milot J; Sadeh J; Boulet LP; O'Byrne PM; Gauvreau GM
    Pulm Pharmacol Ther; 2016 Dec; 41():34-39. PubMed ID: 27640067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule antagonists of the CXCR2 and CXCR1 chemokine receptors as therapeutic agents for the treatment of inflammatory diseases.
    Busch-Petersen J
    Curr Top Med Chem; 2006; 6(13):1345-52. PubMed ID: 16918453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain.
    Carreira EU; Carregaro V; Teixeira MM; Moriconi A; Aramini A; Verri WA; Ferreira SH; Cunha FQ; Cunha TM
    Eur J Pain; 2013 May; 17(5):654-63. PubMed ID: 23132735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
    J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist.
    Nicholson GC; Tennant RC; Carpenter DC; Sarau HM; Kon OM; Barnes PJ; Salmon M; Vessey RS; Tal-Singer R; Hansel TT
    Pulm Pharmacol Ther; 2007; 20(1):52-9. PubMed ID: 16406722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.
    Qiu Y; Zhu J; Bandi V; Atmar RL; Hattotuwa K; Guntupalli KK; Jeffery PK
    Am J Respir Crit Care Med; 2003 Oct; 168(8):968-75. PubMed ID: 12857718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases.
    Boppana NB; Devarajan A; Gopal K; Barathan M; Bakar SA; Shankar EM; Ebrahim AS; Farooq SM
    Exp Biol Med (Maywood); 2014 May; 239(5):509-18. PubMed ID: 24625439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.
    Braber S; Overbeek SA; Koelink PJ; Henricks PA; Zaman GJ; Garssen J; Kraneveld AD; Folkerts G
    Eur J Pharmacol; 2011 Oct; 668(3):443-9. PubMed ID: 21458445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective CXCR2 antagonist SB272844 blocks interleukin-8 and growth-related oncogene-alpha-mediated inhibition of spontaneous neutrophil apoptosis.
    Glynn PC; Henney E; Hall IP
    Pulm Pharmacol Ther; 2002; 15(2):103-10. PubMed ID: 12090783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.
    Wieser V; Adolph TE; Enrich B; Kuliopulos A; Kaser A; Tilg H; Kaneider NC
    Gut; 2017 May; 66(5):930-938. PubMed ID: 26858343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-tuning neutrophil activation: Strategies and consequences.
    van der Linden M; Meyaard L
    Immunol Lett; 2016 Oct; 178():3-9. PubMed ID: 27262927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain.
    Lopes AH; Brandolini L; Aramini A; Bianchini G; Silva RL; Zaperlon AC; Verri WA; Alves-Filho JC; Cunha FQ; Teixeira MM; Allegretti M; Cunha TM
    Pharmacol Res; 2016 Jan; 103():69-79. PubMed ID: 26592483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases.
    Sriskantharajah S; Hamblin N; Worsley S; Calver AR; Hessel EM; Amour A
    Ann N Y Acad Sci; 2013 Mar; 1280():35-9. PubMed ID: 23551101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.